We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Oral AL01211 in Healthy Chinese Volunteers

    Background and Objective

    Aberrant accumulation of glycosphingolipids (GSLs) in the lysosome leads to GSL storage diseases. Glucosylceramide synthase...

    Lei Dong, Jianxing **ang, ... Jianhong Zheng in Clinical Drug Investigation
    Article 02 May 2024
  2. Safety and Tolerability of Combining CGRP Monoclonal Antibodies with Gepants in Patients with Migraine: A Retrospective Study

    Introduction

    The introduction of clacitonin gene-related peptide (CGRP) monoclonal antibodies (mAbs) has revolutionized the treatment of migraines. In...

    Taoufik Alsaadi, Reem Suliman, ... Yazan Bader in Neurology and Therapy
    Article Open access 15 February 2024
  3. Mesenchymal Stem Cell Therapy in Acute Intracerebral Hemorrhage: A Dose-Escalation Safety and Tolerability Trial

    Background

    We conducted a preliminary phase I, dose-escalating, safety, and tolerability trial in the population of patients with acute intracerebral...

    Nisha C. Durand, H. G. Kim, ... Abba C. Zubair in Neurocritical Care
    Article Open access 19 December 2023
  4. Pharmacokinetics, Safety, and Tolerability of Single-Dose Orally Administered Venglustat in Healthy Chinese Volunteers

    Background and Objective

    Deficiencies of enzymes acting downstream of glucosylceramide synthase (GCS) can cause severe substrate accumulation....

    Yingxin Li, Yang Li, ... Aixin Shi in Clinical Drug Investigation
    Article Open access 03 June 2023
  5. Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Stapokibart in Healthy Volunteers and Adult Subjects with Atopic Dermatitis

    Introduction

    Stapokibart, a novel humanized anti-interleukin (IL)-4 receptor alpha monoclonal antibody, inhibits the signaling of IL-4 and IL-13,...

    Libo Zhang, Weilong Zhang, ... Jianzhong Zhang in Advances in Therapy
    Article 04 June 2024
  6. Assessing the safety and tolerability of rhinologic surgery under local anesthetic: an 8-year retrospective analysis

    Purpose

    Office-based rhinologic procedures (OBRP) have become widely available in North America due to technological advances and appropriate patient...

    Andrew Kokavec, Sarah Zahabi, ... Leigh J Sowerby in European Archives of Oto-Rhino-Laryngology
    Article 23 April 2024
  7. Safety and tolerability of Sacubitril/Valsartan in heart failure patient with reduced ejection fraction

    Background

    Angiotensin receptor blocker and a neprilysin inhibitor (ARNI) has emerged as an innovative therapy for patients of heart failure with...

    Muhammad Nauman Khan, Najia Aslam Soomro, ... Musa Karim in BMC Cardiovascular Disorders
    Article Open access 13 March 2023
  8. Safety, Tolerability, and Pharmacokinetics of Oral BI 1358894 in Healthy Japanese Male Volunteers

    Background and Objectives

    BI 1358894, a novel small-molecule inhibitor of transient receptor potential canonical ion channels, is under development...

    Jangsoo Yoon, Vikas Sharma, Akiko Harada in Clinical Drug Investigation
    Article Open access 24 April 2024
  9. Safety, Tolerability and Pharmacokinetics of Single-Dose Oral SYHA1402 in Healthy Chinese Subjects

    Introduction

    To assess the safety, tolerability and pharmacokinetics of a single dose of SYHA1402 in healthy Chinese subjects.

    Methods ...
    Beibei Liang, ** Wang, ... Yun Cai in Neurology and Therapy
    Article Open access 24 April 2023
  10. Safety, Tolerability, and Outcomes of Tafamidis for the Treatment of Acquired Amyloid Neuropathy in Domino Liver Transplant Recipients

    Introduction

    Acquired amyloid neuropathy is an iatrogenic disease that appears years after a domino liver transplant. The objectives of our study are...

    Velina Nedkova-Hristova, Laura Donadeu, ... Carlos Casasnovas in Neurology and Therapy
    Article Open access 10 May 2024
  11. Safety and tolerability of atogepant for the preventive treatment of migraine: a post hoc analysis of pooled data from four clinical trials

    Background

    Conventional, non-specific preventive migraine treatments often demonstrate low rates of treatment persistence due to poor efficacy or...

    Paul Rizzoli, Michael J. Marmura, ... Messoud Ashina in The Journal of Headache and Pain
    Article Open access 11 March 2024
  12. SAFE-ROCK: A Phase I Trial of an Oral Application of the ROCK Inhibitor Fasudil to Assess Bioavailability, Safety, and Tolerability in Healthy Participants

    Background

    The intravenous (IV) formulation of Rho-kinase (ROCK) inhibitor fasudil has been approved for the treatment of subarachnoid haemorrhage...

    Andreas W. Wolff, Jörg Peine, ... Paul Lingor in CNS Drugs
    Article Open access 28 February 2024
  13. Efficacy, safety, and tolerability of antimicrobial agents for complicated intra-abdominal infection: a systematic review and network meta-analysis

    Background

    Which antimicrobial agents provide the optimal efficacy, safety, and tolerability for the empirical treatment of complicated...

    Wenqiang Kong, Ting Deng, ... Yanyan Wu in BMC Infectious Diseases
    Article Open access 21 April 2023
  14. Efficacy, safety, and tolerability of dolutegravir-based ART regimen in Durban, South Africa: a cohort study

    Background

    Dolutegravir is an integrase strand transfer inhibitor that has been recommended for use in first-line antiretroviral regimens by the World...

    Nivriti Hurbans, Panjasaram Naidoo in BMC Infectious Diseases
    Article Open access 21 March 2024
  15. Safety and Tolerability of Antimicrobial Agents in the Older Patient

    Older patients are at high risk of infections, which often present atypically and are associated with high morbidity and mortality. Antimicrobial...

    Luca Soraci, Antonio Cherubini, ... Fabrizia Lattanzio in Drugs & Aging
    Article 28 March 2023
  16. Safety, tolerability, pharmacokinetics and effects of diet on AD16, a novel neuroinflammatory inhibitor for Alzheimer’s disease: a randomized phase 1 study

    Background

    AD16 is a Class 1.1 new drug candidate for Alzheimer’s disease (AD), which has demonstrated potential benefits in AD by reducing...

    Daizhuang Peng, Sumei Xu, ... Qun Qin in BMC Medicine
    Article Open access 23 November 2023
  17. Safety, Tolerability, and Pharmacokinetics of Recombinant Human Neuregulin-1 in Healthy Chinese Subjects

    Background

    We investigated the safety, tolerability, and pharmacokinetics of intravenous recombinant human Neuregulin-1 (rhNRG-1), a DNA recombinant...

    Junyu Xu, Peihong Sun, ... Yimin Cui in American Journal of Cardiovascular Drugs
    Article Open access 18 May 2023
  18. Long-Term Safety and Tolerability of Daridorexant in Patients with Insomnia Disorder

    Background and Objective

    Daridorexant is a dual orexin receptor antagonist for the treatment of insomnia. In two phase III, 12-week studies in...

    Dieter Kunz, Yves Dauvilliers, ... Stephen Thein in CNS Drugs
    Article Open access 09 December 2022
  19. Evaluating adherence, tolerability and safety of oral calcium citrate in elderly osteopenic subjects: a real-life non-interventional, prospective, multicenter study

    Background

    Osteoporosis is a common concern in the elderly that leads to fragile bones. Calcium supplementation plays a crucial role in improving bone...

    Mariangela Rondanelli, Salvatore Minisola, ... Massimo Procopio in Aging Clinical and Experimental Research
    Article Open access 12 February 2024
  20. Long-term safety and tolerability of ambrisentan treatment for pediatric patients with pulmonary arterial hypertension: An open-label extension study

    This open-label, extension study assessed long-term safety, tolerability, and efficacy of ambrisentan in a pediatric population (age 8– < 18 years)...

    Dunbar Ivy, Maurice Beghetti, ... Rolf M. F. Berger in European Journal of Pediatrics
    Article Open access 16 February 2024
Did you find what you were looking for? Share feedback.